CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Trade Fresenius Medical Care AG & Co KGaA - FME CFD
Fresenius Medical Care AG is a global provider of products and services for people suffering from renal failure. Fresenius specialises in dialysis treatment. Additionally, it offers diagnostic and clinical lab testing, ultrasound, respiratory therapy, and echocardiography services. Founded in 1996, the company is headquartered in Bad Homburg, Germany. Today, Fresenius operates in more than 120 countries.
Details on the Fresenius Medical stock price: Fresenius Medical stock is quoted on the Frankfurt Stock Exchange. In 1996, FME stock entered the DAX index, featuring top 30 blue-chip German companies.
Monitor Fresenius Medical Care share price at Capital.com.
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.